Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria

International Journal for Parasitology

Volumn 34, Issue 8, 2004, Pages 935-942

  Bereczky, Sándor ^a   Montgomery, Scott M ^a   Troye Blomberg, Marita ^b   Rooth, Ingegerd ^c   Shaw, Marie Anne ^d   Färnert, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Asymptomatic; IgE; IgG; Malaria; Plasmodium falciparum; Protection

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PYRIMETHAMINE; SULFADOXINE;

MALARIA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POPULATION; REGRESSION ANALYSIS; RISK FACTOR; TANZANIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PREVALENCE; PROGNOSIS; RECURRENCE; RISK FACTORS; TANZANIA;

HUMAN IMMUNODEFICIENCY VIRUS 1; PLASMODIUM FALCIPARUM;

EID: 3042613829     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2004.04.007     Document Type: Article

References (37)

1. Al-Yaman F., Genton B., Reeder J.C., Anders R.F., Smith T., Alpers M.P. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans. R. Soc. Trop. Med. Hyg. 91:1997;602-605
2. Aribot G., Rogier C., Sarthou J.L., Trape J.F., Balde A.T., Druilhe P., Roussilhon C. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am. J. Trop. Med. Hyg. 54:1996;449-457
3. Aucan C., Traore Y., Tall F., Nacro B., Traore-Leroux T., Fumoux F., Rihet P. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect. Immun. 68:2000;1252-1258
4. Bloch P., Simonsen P.E. Immunoepidemiology of Dracunculus medinensis infections II. Variation in antibody responses in relation to transmission season and patency. Am. J. Trop. Med. Hyg. 59:1998;985-990
5. Cohen S., McGregor I.A., Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature. 192:1961;733-737
6. Delley V., Bouvier P., Breslow N., Doumbo O., Sagara I., Diakite M., Mauris A., Dolo A., Rougemont A. What does a single determination of malaria parasite density mean? A longitudinal survey in Mali. Trop. Med. Int. Health. 5:2000;404-412
7. Desowitz R.S. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria. Trans. R. Soc. Trop. Med. Hyg. 83:1989;478-479
8. Desowitz R.S., Elm J., Alpers M.P. Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province, Papua New Guinea. Infect. Immun. 61:1993;988-993
9. Dugas B., Mossalayi M.D., Damais C., Kolb J.P. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today. 16:1995;574-580
10. Farnert A., Snounou G., Rooth I., Bjorkman A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56:1997;538-547
11. Farnert A., Rooth I., Svensson A., Snounou G., Bjorkman A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J. Infect. Dis. 179:1999;989-995
12. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J., Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 349:1991;243-245
13. Heyman B. IgE-mediated enhancement of antibody responses: the beneficial function of IgE? Allergy. 57:2002;577-585
14. Hill A.V. The immunogenetics of resistance to malaria. Proc. Assoc. Am. Physicians. 111:1999;272-277
15. Hussain R., Ottesen E.A. IgE responses in human filariasis. IV. Parallel antigen recognition by IgE and IgG4 subclass antibodies. J. Immunol. 136:1986;1859-1863
16. Jaoko W.G., Simonsen P.E., Meyrowitsch D.W., Pedersen E.M., Rwegoshora R.T., Michael E. Wuchereria bancrofti in a community with seasonal transmission: stability of microfilaraemia, antigenaemia and filarial-specific antibody concentrations. Ann. Trop. Med. Parasitol. 95:2001;253-261
17. Knight J.C., Udalova I., Hill A.V., Greenwood B.M., Peshu N., Marsh K., Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22:1999;145-150
18. Kwiatkowski D., Hill A.V., Sambou I., Twumasi P., Castracane J., Manogue K.R., Cerami A., Brewster D.R., Greenwood B.M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1990;1201-1204
19. Maeno Y., Steketee R.W., Nagatake T., Tegoshi T., Desowitz R.S., Wirima J.J., Aikawa M. Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea. Am. J. Trop. Med. Hyg. 49:1993;574-580
20. McGuire W., Knight J.C., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179:1999;287-290
21. Ndungu F.M., Bull P.C., Ross A., Lowe B.S., Kabiru E., Marsh K. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 24:2002;77-82
22. Oeuvray C., Theisen M., Rogier C., Trape J.F., Jepsen S., Druilhe P. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo. Senegal. Infect. Immun. 68:2000;2617-2620
23. Perlmann H., Helmby H., Hagstedt M., Carlson J., Larsson P.H., Troye-Blomberg M., Perlmann P. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin. Exp. Immunol. 97:1994;284-292
24. Perlmann P., Perlmann H., Flyg B.W., Hagstedt M., Elghazali Worku S., Fernandez V., Rutta A.S., Troye-Blomberg M. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect. Immun. 65:1997;116-121
25. Perlmann P., Perlmann H., Blomberg M.T. IgE, TNF in malaria infection. Protection and pathogenicity: two sides of the same coin. Immunologist. 4/5:1996;179-184
26. Perlmann P., Perlmann H., ElGhazali G., Blomberg M.T. IgE and tumor necrosis factor in malaria infection. Immunol. Lett. 65:1999;29-33
27. Perlmann P., Perlmann H., Looareesuwan S., Krudsood S., Kano S., Matsumoto Y., Brittenham G., Troye-Blomberg M., Aikawa M. Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 62:2000;373-377
28. Pirron U., Schlunck T., Prinz J.C., Rieber E.P. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20:1990;1547-1551
29. Rihet P., Demeure C.E., Bourgois A., Prata A., Dessein A.J. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:1991;2679-2686
30. Rooth I., Bjorkman A. Fever episodes in a holoendemic malaria area of Tanzania: parasitological and clinical findings and diagnostic aspects related to malaria. Trans. R. Soc. Trop. Med. Hyg. 86:1992;479-482
31. Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., Klinnert M., Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy. 25:(Suppl 2):1995;74-78. discussion 95-96
32. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45:1991;297-308
33. Smith T., Felger I., Tanner M., Beck H.P. Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans. R. Soc. Trop. Med. Hyg. 93:(Suppl 1):1999;59-64
34. Snounou G., Zhu X., Siripoon N., Jarra W., Thaithong S., Brown K.N., Viriyakosol S. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:1999;369-974
35. Taylor R.R., Allen S.J., Greenwood B.M., Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58:1998;406-413
36. Troye-Blomberg M. Genetic regulation of malaria infection in humans. Chem. Immunol. 80:2002;243-252
37. van der Heijden F.L., Joost van Neerven R.J., van Katwijk M., Bos J.D., Kapsenberg M.L. J. Immunol. 150:1993;3643-3650